SCHEMBL513845

SCHEMBL513845

[CH2]SCc1cccc(SC(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRZ1 P23471 4/20 0.39
PTPN1 P18031 2/20 0.39
CETP P11597 2/20 0.38
FFAR4 Q5NUL3 1/20 0.37
MAPT P10636 2/20 0.36
ATM Q13315 1/20 0.36
UBE2M P61081 1/20 0.34
DCUN1D1 Q96GG9 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
EPHX1 P07099 1/20 0.32
HTR2C P28335 1/20 0.32
HTR6 P50406 1/20 0.32
KCNH2 Q12809 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL513846 0.82 PTPRZ1 (0.42) PTPRZ1PTPN1CETPFFAR4MAPT
SCHEMBL5422754 0.81 PTPRZ1 (0.41) PTPRZ1PTPN1CETPFFAR4MAPT
SCHEMBL17288832 0.79 FFAR4 (0.39) PTPRZ1PTPN1CETPFFAR4MAPT
SCHEMBL512503 0.78 FFAR4 (0.37) PTPRZ1PTPN1CETPFFAR4MAPT
SCHEMBL934510 0.78 PTPRZ1 (0.41) PTPRZ1PTPN1CETPFFAR4MAPT
SCHEMBL3278395 0.78 CETP (0.42) PTPRZ1PTPN1CETPFFAR4MAPT
SCHEMBL2692232 0.78 CETP (0.42) PTPRZ1PTPN1CETPFFAR4MAPT
SCHEMBL4039392 0.78 CETP (0.42) PTPRZ1PTPN1CETPFFAR4MAPT
SCHEMBL12300586 0.78 CETP (0.41) PTPRZ1PTPN1CETPFFAR4UBE2M
SCHEMBL5729617 0.78 PNMT (0.44) PTPRZ1PTPN1CETPFFAR4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014184070-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 WO disclosed
WO-2014184071-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 WO disclosed
EP-2420493-A1 HALOALKYLSULFONANILIDE DERIVATIVE Nissan Chemical Industries, Ltd. (JP) 2012-02-22 EP disclosed
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-02-02 US disclosed
EP-2336104-A1 ORTHO-SUBSTITUTED HALOALKYLSULFONANILIDE DERIVATIVE AND HERBICIDE Nissan Chemical Industries, Ltd. (JP) 2011-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE CBR3, CBR1, HDHD5 PTPRZ1 477/4885PTPN1 479/4885CETP 4602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.